Simultaneous Control of PTH and Ca×P Is Sustained over Three Years of Treatment with Cinacalcet HCl-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Simultaneous Control of PTH and Ca×P Is Sustained over Three Years of Treatment with Cinacalcet HCl

Published:2009-08-20 Issue:9 Volume:4 Page:1465-1476
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Sprague Stuart M.,Evenepoel Pieter,Curzi Mario P.,González Maria Teresa,Husserl Fred E.,Kopyt Nelson,Sterling Lulu Ren,Mix Chris,Wong Gordon

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference20 articles.

1. Cinacalcet HCl: A Novel Treatment for Secondary Hyperparathyroidism Caused by Chronic Kidney Disease

2. Vintage, nutritional status, and survival in hemodialysis patients

3. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study;Block;Am J Kidney Dis,1998

4. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study

5. Association of elevated serum PO(4), Ca×PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients;Ganesh;J Am Soc Nephrol,2001

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients;Renal Replacement Therapy;2024-03-05

2. Outcomes of subtotal parathyroidectomy for renal hyperparathyroidism;Surgery;2024-03

3. Diagnose und Therapie der Osteoporose bei Patienten mit chronischer Niereninsuffizienz;Wiener Medizinische Wochenschrift;2022-12-21

4. Treatment with Cinacalcet in Hemodialysis Patients with Severe Secondary Hyperparathyroidism, Influences Bone Mineral Metabolism and Anemia Parameters;Current Drug Therapy;2020-10-14

5. Moderne Behandlungsoptionen des sekundären Hyperparathyreoidismus vor dem Hintergrund kardiovaskulärer Kalzifizierung;Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen;2020-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3